Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 11 Lymphoma, Non-Hodgkin 9 Arthritis, Rheumatoid 7 Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Neoplasms 4 Melanoma 4 Lymphoma, B-Cell 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Respiratory Distress Syndrome 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia 2 Hematologic Neoplasms 2 Fallopian Tube Neoplasms 2 Cytokine Release Syndrome 2 Craniopharyngioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 COVID-19 2

Interventions

rozanolixizumab 9 efgartigimod alfa 9 Prednisone 8 zilucoplan 7 Pyridostigmine Bromide 7 Tacrolimus 6 Rituximab 6 Cyclophosphamide 6 telitacicept 5 ravulizumab 5 eculizumab 5 fludarabine 4 Mycophenolic Acid 4 Hizentra 4 Steroids 3 Immunoglobulins, Intravenous 3 HBM9161 3 Azathioprine 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Data Collection 2 Blood Specimen Collection 2 tofacitinib 1 tocilizumab 1 satralizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05716035 2024-01-22

tMG-E

Tang-Du Hospital

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡